STIP study
Recruiting
- Conditions
- Chronic Immune Thrombocytopenia, ITP, TPO-RA, romiplostim, discontinuation
- Registration Number
- NL-OMON22827
- Lead Sponsor
- Haga Teaching Hospital, The Hague
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
•Chronic primary ITP
•>18 years old
Exclusion Criteria
•Splenectomy in history
•Secondary ITP
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remission vs non-remission at 4 weeks after discontinuation of romiplostim treatment
- Secondary Outcome Measures
Name Time Method Possible predictive values for successful cessation. Remission after 12 months, QoL, costs, hospitalisation.